EMA accepts to review Mylan and Biocon’s regulatory submission for Pegfilgrastim
The proposed biosimilar is used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adult patients…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.